Latest clinical information on Zika virus available at info centers on Elsevier Connect and The Lancet
- Details
- Category: Development
To help healthcare professionals, medical researchers and the public understand the ongoing outbreak of the Zika virus, Elsevier has created a Zika Virus Resource Center on Elsevier's public news and information website. In addition, The Lancet, one of Elsevier's top medical journals, has created a Zika virus resource centre on its website,
Are you working on a big bang company?
- Details
- Category: Development

Drug development crisis linked to bad technology choices, experts argue
- Details
- Category: Development
The search for new medicines is becoming unsustainably expensive despite huge technological advances because researchers are using the wrong methods, experts say. They say drug discovery should focus on 'validity' - how well the results of experiments predict results in sick people. Instead, it has focused on methods that are easy to industrialize or methods that are academically fashionable.
LIGHTSABR - a cheap, portable drug-discovery system
- Details
- Category: Development
Screening large "libraries" of compounds to find those with a desired biological activity is a powerful method for discovering new drugs, but requires a large, expensive and dedicated facility. Now, scientists at the Florida campus of The Scripps Research Institute (TSRI) have devised the central component of a screening system that would be orders of magnitude smaller and cheaper.
Clinical investigations of MRT are 'ethically permissible' if conditions met
- Details
- Category: Development
Conducting clinical investigations of mitochondrial replacement techniques (MRT) in humans is ethically permissible as long as significant conditions and principles are met, says a new report from the National Academies of Sciences, Engineering, and Medicine.
The effects of the Trans-Pacific Partnership on pharmaceutical innovation
- Details
- Category: Development
The Trans-Pacific Partnership (TPP) is a multi-national trade agreement now being considered by 12 countries. In an insightful commentary in Research in Social and Administrative Pharmacy (RSAP), the ramifications of major components of the agreement are discussed, especially those potentially impacting the worldwide pharmaceutical industry.
Global pharmaceutical industry calls on governments to work with them to beat the rising threat of drug resistance
- Details
- Category: Development
More than 80 leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well as key industry bodies, have come together to call on governments and industry to work in parallel in taking comprehensive action against drug-resistant infections - so-called 'superbugs' - with a joint declaration launched today at the World Economic Forum in Davos, Switzerland.
More Pharma News ...
- Stop spoon dosing
- Leading medical journals propose mandate on clinical data sharing
- New therapy aids bid to beat organ failure caused by pancreatitis
- New open access journal highlights methods and clinical trial results
- One step closer to personalized medicine
- Armed malaria protein found to kill cancer cells
- Teva Pharmaceuticals and IBM partner to build global e-Health solutions on the IBM Watson Health Cloud